Earnings Call Excerpt
Kos Pharmaceuticals (KOSP)
Q4 2005 Earnings Conference Call
February 23rd 2006, 8:30 AM.
Executives:
John Howarth, VP, IR
Adrian Adams, President & CEO
Kevin Clark, EVP. CFO
Juan Rodriguez, SVP & Controller
Analysts:
Ken Trbovich, RBC Capital Markets
Gregg Gilbert, Merrill Lynch.
Robert Hazlett, Suntrust Robinson Humphrey
Amy Stevens, SIG
Ian Sanderson, Cowen & Company
Steve DeNelsky, Safire Capital
Stelis Senenar, Investment
Robert Hazlett, Suntrust Robinson
Ken Trbovich, RBC Capital Markets
Presentation
Operator
Good day everyone, and welcome to the Kos Pharmaceuticals, Fourth Quarter and Full Year 2005 Conference Call. Today's conference is being recorded. At this time I would like to turn the conference over to Vice President of Investor Relation Jack Howarth. Please go ahead sir.
Jack Howarth, Vice President and Investor Relation
Thank you Glenn and good morning everyone. Welcome to Kos' fourth quarter and full year 2005 earnings conference call. Joining me on this morning's call are Adrian Adams, President and Chief Executive Officer, Kevin Clark, Executive Vice President and Chief Financial Officer, and Juan Rodriguez, Senior Vice President and Controller and Corporate Administration. I hope you all had a chance to review today's earnings release as well as our research and development milestone release. If you have any additional questions following this conference call, please feel free to call either Nichol Harber or me. I would also like to call your attention to the slides that company are remarks this morning. You can access the slides by going to the Investor Relation section of our website and clicking on the icon marked `Fourth-quarter conference call`.
Before we begin to discuss our results you should be reminded that this conference call will contained forward-looking statements that are intended to fall within the Safe Harbor provisions Under the Private Securities Litigation Reform Act. Several factors could cause actual events to differ materially from the forward-looking statements including those factors listed in the forward-looking information certain cautionary statements section of the Company's annual report on Form 10-K, to be filed with the SEC for the year ending December 31st 2005 and factors identified in other reports filed with the SEC. I would now like to turn the conference call over to Adrian who will highlight the key business and financial accomplishments for the fourth quarter and full year. Then Jaun and Clark will present the 2006 outlook and we will then open the call for your questions. Adrian will return at the end of the question and answer period to wrap up the call. Adrian, please go ahead.
Thank you, if you would like to ask a question please do so by pressing the ?*’ follow by a digit ?1
- To read the full transcript on Seeking Alpha, click here »
